Memory Stocks Surge, Early xAI & SpaceX Investor Peter Diamandis, Teva Pharma CEO 4/29/26
What does the surge in memory stocks signal about the broader AI trade? A look at those moves, ahead of four Mag 7 earnings reports tonight. Then early SpaceX and xAI investor Peter Diamandis on Elon Musk’s lawsuit against OpenAI. Plus, how to value a SpaceX IPO. And the CEO of Teva Pharma after reporting an earnings beat and announcing its first acquisition in a decade. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from CNBC’s “Money Movers”
Artemis II Astronauts Land at NYSE, Big Oil Reports, Apple’s Demand Picture 5/1/26
Qualcomm & JLL CEOs on Earnings, Meta Shares Plunge, Gas Prices Hit New Highs 4/30/26
Report on OpenAI Revenue Rattles AI Trade, Novartis and Shell CEOs 4/28/26
Bridgewater Founder Ray Dalio, Setup for Tech Earnings, Calls for DHS Funding Grow 4/27/26
Get summaries like this every morning.
Free AI-powered recaps of CNBC’s “Money Movers” and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.